Use of Intraaortic Balloon Counterpulsation in Patients Presenting With Cardiogenic Shock: Observations From the GUSTO-I Study fn1fn1This study was funded by grants from Bayer, New York, New York; CIBA-Corning, Medfield, Massachusetts; Genentech, South San Francisco, California; ICI Pharmaceuticals, Wilmington, Delaware; and Sanofi Pharmaceuticals, Paris, France.
1997 ◽
Vol 30
(3)
◽
pp. 708-715
◽
2012 ◽
Vol 157
(12)
◽
pp. JC6
1977 ◽
Vol 62
(5)
◽
pp. 687-692
◽
2014 ◽
Vol 64
(16)
◽
pp. C133
2015 ◽
Vol 104
(8)
◽
pp. 679-687
◽
1975 ◽
Vol 58
(2)
◽
pp. 183-191
◽
2017 ◽
Vol 70
(18)
◽
pp. B228-B229